CRIZANLIZUMAB (KRIZ an LIZ ue mab) prevents the symptoms of sickle cell disease, such as pain crises and acute chest syndrome. It works by preventing blood cells from clumping together. This increases blood flow and the amount of oxygen that gets to your tissues. It is a monoclonal antibody.


ADAKVEO Information

En Español En Español

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.